• Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials

  • Apr 8 2024
  • Duración: 11 m
  • Podcast

Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials Por arte de portada

Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer.

    Read the full article:
    https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00040-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc

    Tell us what you thought about this episode

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles